MMP3 and hepatocellular carcinoma: MMP-3 polymorphism (genetic variants) has been associated with poor HCC prognosis and primary sclerosing cholangitis (PSC), a cholestatic liver disease characterized by chronic inflammation and progressive inter- and intrahepatic biliary fibrosis [52,53,55].